FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955462834> ?p ?o ?g. }

• W2955462834 endingPage "2350" @default.
• W2955462834 startingPage "2341" @default.
• W2955462834 abstract "Aims To propose new exposure targets for Bayesian dose optimisation suited for high‐dose rifampicin and to apply them using measured plasma concentrations coupled with a Bayesian forecasting algorithm allowing predictions of future doses, considering rifampicin's auto‐induction, saturable pharmacokinetics and high interoccasion variability. Methods Rifampicin exposure targets for Bayesian dose optimisation were defined based on literature data on safety and anti‐mycobacterial activity in relation to rifampicin's pharmacokinetics i.e. highest plasma concentration up to 24 hours and area under the plasma concentration–time curve up to 24 hours (AUC 0–24h ). Targets were suggested with and without considering minimum inhibitory concentration (MIC) information. Individual optimal doses were predicted for patients treated with rifampicin (10 mg/kg) using the targets with Bayesian forecasting together with sparse measurements of rifampicin plasma concentrations and baseline rifampicin MIC. Results The suggested exposure target for Bayesian dose optimisation was a steady state AUC 0–24h of 181–214 h × mg/L. The observed MICs ranged from 0.016–0.125 mg/L (mode: 0.064 mg/L). The predicted optimal dose in patients using the suggested target ranged from 1200–3000 mg (20–50 mg/kg) with a mode of 1800 mg (30 mg/kg, n = 24). The predicted optimal doses when taking MIC into account were highly dependent on the known technical variability of measured individual MIC and the dose was substantially lower compared to when using the AUC 0–24h ‐only target. Conclusions A new up‐to‐date exposure target for Bayesian dose optimisation suited for high‐dose rifampicin was derived. Using measured plasma concentrations coupled with Bayesian forecasting allowed prediction of the future dose whilst accounting for the auto‐induction, saturable pharmacokinetics and high between‐occasion variability of rifampicin." @default.
• W2955462834 created "2019-07-12" @default.
• W2955462834 creator A5004848467 @default.
• W2955462834 creator A5013955124 @default.
• W2955462834 creator A5017537112 @default.
• W2955462834 creator A5024502790 @default.
• W2955462834 creator A5030569559 @default.
• W2955462834 creator A5037967289 @default.
• W2955462834 creator A5050797401 @default.
• W2955462834 creator A5085060070 @default.
• W2955462834 date "2019-07-25" @default.
• W2955462834 modified "2023-10-16" @default.
• W2955462834 title "Individualised dosing algorithm and personalised treatment of high‐dose rifampicin for tuberculosis" @default.
• W2955462834 cites W105671925 @default.
• W2955462834 cites W1821013229 @default.
• W2955462834 cites W1976696095 @default.
• W2955462834 cites W1986157879 @default.
• W2955462834 cites W2011120498 @default.
• W2955462834 cites W2027951201 @default.
• W2955462834 cites W2034664377 @default.
• W2955462834 cites W2059185356 @default.
• W2955462834 cites W2060839842 @default.
• W2955462834 cites W2063292102 @default.
• W2955462834 cites W2068357196 @default.
• W2955462834 cites W2091054826 @default.
• W2955462834 cites W2092411341 @default.
• W2955462834 cites W2095750649 @default.
• W2955462834 cites W2107834145 @default.
• W2955462834 cites W2123569837 @default.
• W2955462834 cites W2129441585 @default.
• W2955462834 cites W2132846513 @default.
• W2955462834 cites W2141228465 @default.
• W2955462834 cites W2143942591 @default.
• W2955462834 cites W2163491269 @default.
• W2955462834 cites W2164438043 @default.
• W2955462834 cites W2169203610 @default.
• W2955462834 cites W2175285026 @default.
• W2955462834 cites W2328917954 @default.
• W2955462834 cites W2543303947 @default.
• W2955462834 cites W2547937482 @default.
• W2955462834 cites W2726956036 @default.
• W2955462834 cites W2771362836 @default.
• W2955462834 cites W2773907647 @default.
• W2955462834 cites W2789528825 @default.
• W2955462834 cites W2802200589 @default.
• W2955462834 cites W2809467692 @default.
• W2955462834 cites W2887184336 @default.
• W2955462834 cites W2889510886 @default.
• W2955462834 cites W2911945528 @default.
• W2955462834 cites W2912656707 @default.
• W2955462834 cites W97420631 @default.
• W2955462834 doi "https://doi.org/10.1111/bcp.14048" @default.
• W2955462834 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6783589" @default.
• W2955462834 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31269277" @default.
• W2955462834 hasPublicationYear "2019" @default.
• W2955462834 type Work @default.
• W2955462834 sameAs 2955462834 @default.
• W2955462834 citedByCount "11" @default.
• W2955462834 countsByYear W29554628342020 @default.
• W2955462834 countsByYear W29554628342021 @default.
• W2955462834 countsByYear W29554628342022 @default.
• W2955462834 countsByYear W29554628342023 @default.
• W2955462834 crossrefType "journal-article" @default.
• W2955462834 hasAuthorship W2955462834A5004848467 @default.
• W2955462834 hasAuthorship W2955462834A5013955124 @default.
• W2955462834 hasAuthorship W2955462834A5017537112 @default.
• W2955462834 hasAuthorship W2955462834A5024502790 @default.
• W2955462834 hasAuthorship W2955462834A5030569559 @default.
• W2955462834 hasAuthorship W2955462834A5037967289 @default.
• W2955462834 hasAuthorship W2955462834A5050797401 @default.
• W2955462834 hasAuthorship W2955462834A5085060070 @default.
• W2955462834 hasBestOaLocation W29554628341 @default.
• W2955462834 hasConcept C105795698 @default.
• W2955462834 hasConcept C107673813 @default.
• W2955462834 hasConcept C112705442 @default.
• W2955462834 hasConcept C176947019 @default.
• W2955462834 hasConcept C185592680 @default.
• W2955462834 hasConcept C2777288759 @default.
• W2955462834 hasConcept C2778607973 @default.
• W2955462834 hasConcept C3020079912 @default.
• W2955462834 hasConcept C33923547 @default.
• W2955462834 hasConcept C501593827 @default.
• W2955462834 hasConcept C55493867 @default.
• W2955462834 hasConcept C71924100 @default.
• W2955462834 hasConcept C76318530 @default.
• W2955462834 hasConcept C98274493 @default.
• W2955462834 hasConceptScore W2955462834C105795698 @default.
• W2955462834 hasConceptScore W2955462834C107673813 @default.
• W2955462834 hasConceptScore W2955462834C112705442 @default.
• W2955462834 hasConceptScore W2955462834C176947019 @default.
• W2955462834 hasConceptScore W2955462834C185592680 @default.
• W2955462834 hasConceptScore W2955462834C2777288759 @default.
• W2955462834 hasConceptScore W2955462834C2778607973 @default.
• W2955462834 hasConceptScore W2955462834C3020079912 @default.
• W2955462834 hasConceptScore W2955462834C33923547 @default.
• W2955462834 hasConceptScore W2955462834C501593827 @default.
• W2955462834 hasConceptScore W2955462834C55493867 @default.
• W2955462834 hasConceptScore W2955462834C71924100 @default.

• next